The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline

Neurological Sciences

Volumn 31, Issue SUPPL.1, 2010, Pages

  Valguarnera, Fabio ^a   Tanganelli, Paolo ^a  

^a PA Micone Hospital   (Italy)

Author keywords

Chronic daily headache; Medication overuse; Topiramate amitriptyline; Withdrawal therapy

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; DEXAMETHASONE; DIAZEPAM; ERGOTAMINE DERIVATIVE; OPIATE DERIVATIVE; TOPIRAMATE; TRIPTAN DERIVATIVE; DRUG DERIVATIVE; FRUCTOSE;

ADULT; AGED; ARTICLE; CHRONIC TENSION HEADACHE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROPHYLAXIS; TRANSFORMED MIGRAINE; TREATMENT INDICATION; TREATMENT WITHDRAWAL; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; HEADACHE AND FACIAL PAIN; MIDDLE AGED; PATIENT SELECTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; CHRONIC DISEASE; FEMALE; FRUCTOSE; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 77955879280     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-010-0319-0     Document Type: Article

References (14)

1. Diener HC, Limmroth V (2004) Medication overuse headache: A worldwide problem. Lancet Neurol 3:475-483 (Pubitemid 38903098)
2. Castillo J, Munoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 39:190-196 (Pubitemid 29190083)
3. Manack A, Turkel C, Silberstein S (2009) The evolution of chronic migraine: classification a nomenclature. Headache 49:1206-1213
4. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9-160
5. Saper JR, Hamel RL, Lake AE III (2005) Medication overuse headache (MOH) is a behavioural disorder. Cephalalgia 25:545-546 (Pubitemid 40896021)
6. Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD (2005) Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: A randomized doubleblind, placebo-controlled study. Headache 45:315-324 (Pubitemid 40530195)
7. Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: A randomized double-blind, placebo-controlled trial. Headache 45:293-307 (Pubitemid 40530193)
8. Grazzi L, Andrasik F (2006) Medication overuse headache: description, treatment and relapse prevention. Curr Pain Headache Rep 10:71-77
9. Silberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 34:1-7 (Pubitemid 24038967)
10. Dierer HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ (2007) Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia 27:814-823 (Pubitemid 46961730)
11. Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine and cluster headache with topiramate. Headache 42:796-803 (Pubitemid 35291515)
12. Ziegler DK, Hurwitz A, Hassaneim RS, Kodanaz HA, Preskom SH, Mason J (1987) Migraine prophylaxis: A comparison of propranolol and amitriptyline. Arch Neurol 44:486-489 (Pubitemid 17061928)
13. Mathew NT (1981) Prophylaxis of migraine and mixed headache: A randomized controlled study. Headache 21:105-109 (Pubitemid 11070443)
14. Couch JR, Hassaneim RS (1979) Amitriptyline in migraine prophylaxis. Arch Neurol 36:695-699 (Pubitemid 10226313)